FindTrial
Sign In

Comparison of two pain mitigation strategies of a minimally invasive surgical technique in patients suffering from plantar fasciitis, which is refractory to medical management

Comparison of super selective transcatheter arterial embolization versus non-selective ultrasound guided embolization technique in plantar fascitis refractory to conservative management: an open-label pilot randomised controlled trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097656
Enrollment
24
Registered
2025-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M70- Soft tissue disorders related to use, overuse and pressure Health Condition 2: M722- Plantar fascial fibromatosis Health Condition 3: Z48- Encounter for other postproceduralaftercare

Interventions

Intervention1: Non selective USG (Ultrasound) guided embolization technique in plantar fascitis.: Drug-Imipenem-cilastatin sodium, Dose- Single injection (500 mg reconsituted in 7 cc saline), Mode-

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A patient with 1. Tenderness at the calcaneal attachment 2. Thickened plantar fascia (more than 4 mm) on preprocedural MRI. 3. No meaningful improvement with more than 3 months of conservative treatment (rest, anti-inflammatory drugs, and physical therapy)

Exclusion criteria

Exclusion criteria: 1. Uncorrectable coagulopathy as defined by INR more than 2.5 or platelet count less than 30,000 2. Iodine allergy resulting in anaphylaxis 3. Renal dysfunction as defined by eGFR of less than 30 4. Currently pregnant 5. Previous foot surgery 6. Not giving consent for the study

Design outcomes

Primary

MeasureTime frame
Technical success, Post procedural pain reliefTimepoint: 24 hours, 7 days, 1 month, 3 month, 6 month, 12 month—

Secondary

MeasureTime frame
Requirement of multiple reinterventions, ComplicationsTimepoint: 24 hours, 7 days, 1 month, 3 month, 6 month, 12 month—

Countries

India

Contacts

Public ContactDr Priya Jagia

AIl India Institite of Medical Sciences (AIIMS), New Delhi

drpjagia@yahoo.com09868114037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026